Developer docs
API playgroundTry for free, no card

Search company profiles

Teknova

Full company profile

uuid0000uzo

Namestring
Teknova
Legal namestring
Alpha Teknova, Inc.
Websiteurl
teknova.com
Company typeenum
Public
Founded yearint
1996
Descriptiontext

Teknova (Alpha Teknova, Inc., NASDAQ: TKNO) is a publicly traded life sciences reagent manufacturer founded in 1996 and headquartered in Hollister, California. The company produces critical reagents for the life sciences industry, including buffers, agar plates, microbial culture media, cryopreservation media (PluriFreeze), water products (including WFI Quality Water), and a proprietary AAV•Tek Solutions line covering adeno-associated virus (AAV) gene therapy workflows—comprising AAV Stabilizer (yield gains up to 50%), AEX Buffer Screening Kit (85%+ full capsid enrichment), and PCR Sample Prep Kit. Operations run from over 180,000 square feet of ISO 13485-certified manufacturing space with more than 10,000 square feet of ISO 7 and 8 cleanrooms, supporting lot sizes up to 2,000 liters and serving more than 3,000 customers across academic, biotechnology, and biopharmaceutical end markets.

The company's revenue is generated through three streams: off-the-shelf catalog products (1,400+ ready-to-use formulations sold via direct e-commerce and global distributors Fisher Scientific and VWR), custom manufacturing services (minimums as low as 8 sleeves or 8 liters, plus the expedited Express•Tek Production service), and ISO 13485 GMP manufacturing for clinical and commercial production including OEM kitting. Pricing is predominantly unit-based and quote-based, with GMP contracts typically structured as multi-year agreements. The proprietary modular manufacturing platform—featuring a bracketed quality management system, continuous production, and burst capacity—enables seamless tech transfer from RUO through the new RUO+ grade and into GMP. Financial reporting is split between Lab Essentials (catalog/reagent products, $8.4M in Q1 2026, +3% YoY) and Clinical Solutions (GMP and clinical-grade products, $2.1M in Q1 2026, +85% YoY), with FY2025 total revenue of $40.5 million (+7% YoY), gross margin of 33.2% (a 1,400 bps improvement), and FY2026 guidance of $42–$44 million.

Strategic positioning centers on capturing growth in cell and gene therapy bioprocessing through proprietary reagent IP (AAV•Tek, PluriFreeze), strategic co-development partnerships (notably with Sartorius BIA Separations for combined AAV purification workflows), and a content-marketing-driven demand generation model supported by 80+ peer-reviewed publication citations and an industry webinar series (Teknova Talks). Distribution combines direct e-commerce, a custom order configurator, and a global distributor network, with procurement integrations into SAP Ariba and Coupa for enterprise customers.

Short descriptiontext

Teknova manufactures critical life sciences reagents—buffers, agar plates, microbial culture media, cryopreservation media, water, and proprietary AAV•Tek gene therapy solutions—for 3,000+ academic, biotech, and biopharma customers across RUO and GMP grades.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersHollister, United States
HQ citystring
Hollister
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science reagents, custom reagent manufacturing, GMP manufacturing services, cell therapy reagents, buffer solutions
Industry4 codes
PRIMARYHLAGAGAI
Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Food Manufacturing311
SIC code2 codes
  • Miscellaneous Chemical Products2890
  • Services-Commercial Physical & Biological Research8731
Product category
Life Sciences Reagents and Manufacturing Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Off-the-shelf Catalog Products
TypeOne Time License
Description

Sale of over 1,400 ready-to-use reagent formulations including buffers, agar plates, culture media, cryopreservation media, and water products. Products available in various formats from tubes to 200L bags. Revenue from standard product catalog with various container sizes and grades (RUO, GMP).

teknova.com
2Custom Manufacturing Services
TypeOne Time License
Description

Custom reagent formulation and manufacturing services with low minimum orders (as low as 8 sleeves of agar plates or 8 L of broths/buffers). Includes custom formats, formulations, and quality control testing. Features Express•Tek Production for expedited turnaround in days instead of weeks.

teknova.com
3GMP Manufacturing
TypeProfessional Services
Description

ISO 13485 certified manufacturing services for GMP-grade products supporting clinical and commercial production. Services include custom GMP reagents, OEM kitting, and stability studies for shelf-life determination.

teknova.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1AAV•Tek PCR Sample Prep Kit (DNase I Treatment + Dilution Buffer)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$473.00 per kit (Product ID 21445), includes DNase I Treatment Kit and 10X Dilution Buffer tubes. Alternative version with dilution plates is $631.00 (Product ID 21444).

teknova.com
2Custom Manufacturing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Custom order minimums as low as 8 sleeves of agar plates or 8 L of broths, buffers, and reagents. Pricing varies based on formulation, volume, container format, and quality requirements.

teknova.com
3GMP Manufacturing Services
ModelUnit PricingBilling cadenceMulti-year contract
Notes

GMP-grade products available in catalog formats from 100mL to 200L. Custom GMP manufacturing quote-based with pricing dependent on specifications, lot size, and testing requirements.

teknova.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1AAV•Tek Solutions
Description

Proprietary suite of novel reagents designed to streamline gene therapy workflows, including AAV Stabilizer, AEX Buffer Screening Kit, and PCR Sample Prep Kit for adeno-associated virus applications.

teknova.com
+3 more records
Core offering1 text field

Teknova manufactures and sells critical reagents and buffers for the life sciences industry across product lines including AAV•Tek Solutions (proprietary AAV gene therapy reagents), Agar Plates, Buffers and Reagents, PluriFreeze Cryopreservation Media, Dry Powders, Microbial Culture Media, and Water products available in RUO, RUO+, and GMP grades. The company complements its catalog with custom manufacturing, GMP manufacturing, OEM kitting, and Express•Tek expedited production services, serving over 3,000 customers in gene therapy, cell therapy, molecular diagnostics, synthetic biology, and academic research through 180,000+ square feet of ISO 13485 certified manufacturing facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 50% increase in AAV yield with AAV Stabilizer
+4 more records
Product overview1 text field

Teknova is a manufacturer of critical reagents for the life sciences industry, operating as a platform of modular product lines supported by manufacturing services. The core portfolio includes AAV•Tek Solutions (proprietary AAV gene therapy reagents including PCR Sample Prep Kit, AAV Stabilizer, and AEX Buffer Screening Kit), Agar Plates, Buffers and Reagents, Cryopreservation Media (PluriFreeze), Dry Powders, Microbial Culture Media, and Water products—all available in RUO, RUO+, and GMP manufacturing grades. These product lines are complemented by service offerings including GMP Manufacturing, OEM Kitting, Express•Tek Production, and Custom Manufacturing, enabling customers to transition from research through commercialization. The company supports end-to-end workflows for AAV gene therapy and plasmid production, with over 1,400 ready-to-use formulations and more than 3,000 customers across academia, biotechnology, and biopharmaceuticals.

Product and service11 records
1AAV•Tek Solutions
CategoryGene therapy reagents
Description

Proprietary suite of innovative reagents designed to streamline adeno-associated virus (AAV) gene therapy workflows, addressing critical pain points in downstream processing including polishing, sample preparation, and capsid enrichment. Targeted at biopharmaceutical and biotechnology companies developing gene therapies.

2Agar Plates
CategoryMicrobiological culture media
Description

Pre-poured agar plates including bacterial culture media (Brain Heart Infusion, LB, M9, MacConkey, Mannitol Salt, m-Endo, Middlebrook, MRS, Mueller Hinton, Nutrient, Plate Count, Pseudomonas, R2A, Reinforced Clostridial, Salmonella Shigella, SOB/SOC, TB, Tryptic Soy, XLD, 2xYT) and yeast and fungal culture media. Used by life sciences researchers and microbiology labs.

3Buffers and Reagents
CategoryBuffers and laboratory reagents
Description

Comprehensive range of buffers and reagents including acids and bases, additives, alcohol solutions, antibiotic solutions, biological buffers (Bis-Tris, HEPES, Histidine, MES, MOPS, PBS, Potassium Phosphate, Sodium Citrate, Tris), chaotropic agents, molecular biology solutions, salt solutions, sugar solutions, and surfactants/detergents. Used across life sciences research, molecular biology, and bioprocessing.

4PluriFreeze Cryopreservation Media
CategoryCell therapy reagents
Description

PluriFreeze cryopreservation media system including PluriFreeze Base and PluriFreeze PF10, both available in RUO and GMP grades. Novel low-viscosity solution designed for large-scale cryopreservation in closed systems. Targeted at cell therapy developers and manufacturers.

5Dry Powders
CategoryMicrobiological culture media
Description

Dry powder products including additives (amino acids, plating beads), antibiotic powders, bacterial culture media (Brain Heart Infusion, LB, M9, Mueller-Hinton, SOB/SOC, Super Broth, TB, Tryptic Soy, 2xYT), salt solutions, surfactants/detergents, and yeast/fungal media. Used for microbiology and molecular biology applications.

6Microbial Culture Media
CategoryMicrobiological culture media
Description

Liquid microbial culture media including bacterial culture media (Brain Heart Infusion, LB, M9 Minimal, Mueller-Hinton, Nutrient Broth, SOB/SOC, Super Broth, Synthetic Defined, TB, Tryptic Soy, 2xYT) and yeast and fungal media (Buffered Complex Broths, Complete Minimal, Sabouraud Dextrose, Synthetic Defined, Yeast Peptone Dextrose).

7Water Products
CategoryLaboratory water and reagents
Description

Water products including PCR Certified Water (DNase/RNase/Endotoxin Tested), Reagent Grade Water, and WFI Quality Water, available in various formats from tubes to 200L bags. Used in molecular biology, bioprocessing, and pharmaceutical applications.

8GMP Manufacturing Services
CategoryContract manufacturing services
Description

ISO 13485 certified GMP manufacturing services with over 10,000 square feet of ISO 7 and 8 cleanrooms, featuring cutting-edge automation, continuous production, and burst capacity for lot sizes up to 2,000 L. Serves clinical and commercial-stage biopharmaceutical and biotechnology customers.

9OEM Kitting
CategoryContract manufacturing services
Description

Original equipment manufacturer kitting services for assembling and packaging custom reagent configurations. Serves companies that require private-label or bundled reagent kits for their customers or distribution channels.

10Express•Tek Production
CategoryContract manufacturing services
Description

Expedited custom formulation production service that delivers products in days instead of weeks, featuring pre-ordered raw materials, prioritized manufacturing, and overnight shipping with guaranteed turnaround. Serves customers requiring fast turnaround for time-sensitive research or production needs.

11Custom Manufacturing
CategoryContract manufacturing services
Description

Custom reagent manufacturing with low minimum order quantities (as low as 8 sleeves of agar plates or 8 L of broths/buffers), flexible container formats, and comprehensive QC testing. Services include stability studies and a custom order configurator. Serves life sciences researchers and manufacturers needing tailored formulations.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research partnership focused on AAV downstream processing optimization. The collaboration demonstrated successful achievement of over 85% full AAV capsid enrichment with 80-90% recoveries when pairing Teknova's optimized AEX Buffer Screening Kit with Sartorius BIA Separations' CIMmultus QA monolith. Joint webinars and published data support the partnership. Quote from Managing Director Aleš Štrancar highlights the importance of combining purification platform with buffer composition for successful AAV empty and full capsid separation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest life sciences tools company, with Gibco-branded cell culture media, buffers, and bioproduction reagents overlapping directly with Teknova's catalog; also serves biopharma through Patheon CDMO services and Fisher Scientific distribution that competes with Teknova's own Fisher channel.

2Corning Life Sciences
TypeBroad incumbent
Description

Supplies cell culture media, sera, and bioprocess containers alongside its core lab consumables business; overlaps with Teknova's liquid microbial culture media and water products serving similar life sciences customers.

TypeDirect peer
Description

Privately held Canadian life sciences company specializing in cell culture media, cryopreservation reagents, and cell therapy workflow products — directly comparable to Teknova's PluriFreeze and microbial culture media lines serving similar academic and biopharma customers.

TypeBroad incumbent
Description

Public developer and manufacturer of life science reagents, proteins, and cell/gene therapy workflow tools including the recently acquired BioLegend portfolio — overlapping with Teknova's reagent and cell therapy media offerings.

TypeBroad incumbent
Description

Bioprocessing equipment and consumables leader, parent of BIA Separations — Teknova's explicit AAV downstream co-development partner. Overlapping reagent and buffer offerings make Sartorius a strategic competitor as well as collaborator.

TypeBroad incumbent
Description

Global supplier of products, services, and solutions for life sciences and advanced technology customers, including bioproduction buffers and reagents through the VWR distribution channel that also carries Teknova's products.

TypeBroad incumbent
Description

Danaher-owned bioprocessing leader offering chromatography resins, buffers, and consumables including the CIMmultus QA monolith — Teknova's AAV•Tek AEX kit is paired with Cytiva/Sartorius platforms, making Cytiva a direct channel and technology peer with vastly greater scale.

8Merck KGaA / MilliporeSigma
TypeBroad incumbent
Description

Operates one of the broadest portfolios of buffers, reagents, and bioprocessing inputs including the BioReliance CDMO testing services; competes across Teknova's entire catalog and offers deeper customization for larger GMP customers.

TypeDirect peer
Description

Manufacturer of cell culture media, reagents, and GMP-grade bioprocessing inputs for cell and gene therapy — directly comparable to Teknova's GMP manufacturing services and PluriFreeze cryopreservation media targeting the same therapy developers.

TypeBroad incumbent
Description

Global biopharma CDMO and manufacturer of cell and gene therapy media and buffers; comparable to Teknova's GMP manufacturing and cryopreservation offerings but with substantially larger scale and broader service portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Teknova

Life Sciences Reagents and Manufacturing Servicesteknova.com

Teknova manufactures critical life sciences reagents—buffers, agar plates, microbial culture media, cryopreservation media, water, and proprietary AAV•Tek gene therapy solutions—for 3,000+ academic, biotech, and biopharma customers across RUO and GMP grades.

What Teknova does

Teknova (Alpha Teknova, Inc., NASDAQ: TKNO) is a publicly traded life sciences reagent manufacturer founded in 1996 and headquartered in Hollister, California. The company produces critical reagents for the life sciences industry, including buffers, agar plates, microbial culture media, cryopreservation media (PluriFreeze), water products (including WFI Quality Water), and a proprietary AAV•Tek Solutions line covering adeno-associated virus (AAV) gene therapy workflows—comprising AAV Stabilizer (yield gains up to 50%), AEX Buffer Screening Kit (85%+ full capsid enrichment), and PCR Sample Prep Kit. Operations run from over 180,000 square feet of ISO 13485-certified manufacturing space with more than 10,000 square feet of ISO 7 and 8 cleanrooms, supporting lot sizes up to 2,000 liters and serving more than 3,000 customers across academic, biotechnology, and biopharmaceutical end markets.

The company's revenue is generated through three streams: off-the-shelf catalog products (1,400+ ready-to-use formulations sold via direct e-commerce and global distributors Fisher Scientific and VWR), custom manufacturing services (minimums as low as 8 sleeves or 8 liters, plus the expedited Express•Tek Production service), and ISO 13485 GMP manufacturing for clinical and commercial production including OEM kitting. Pricing is predominantly unit-based and quote-based, with GMP contracts typically structured as multi-year agreements. The proprietary modular manufacturing platform—featuring a bracketed quality management system, continuous production, and burst capacity—enables seamless tech transfer from RUO through the new RUO+ grade and into GMP. Financial reporting is split between Lab Essentials (catalog/reagent products, $8.4M in Q1 2026, +3% YoY) and Clinical Solutions (GMP and clinical-grade products, $2.1M in Q1 2026, +85% YoY), with FY2025 total revenue of $40.5 million (+7% YoY), gross margin of 33.2% (a 1,400 bps improvement), and FY2026 guidance of $42–$44 million.

Strategic positioning centers on capturing growth in cell and gene therapy bioprocessing through proprietary reagent IP (AAV•Tek, PluriFreeze), strategic co-development partnerships (notably with Sartorius BIA Separations for combined AAV purification workflows), and a content-marketing-driven demand generation model supported by 80+ peer-reviewed publication citations and an industry webinar series (Teknova Talks). Distribution combines direct e-commerce, a custom order configurator, and a global distributor network, with procurement integrations into SAP Ariba and Coupa for enterprise customers.

Teknova firmographics

Firmographics
Name
Teknova
Legal name
Alpha Teknova, Inc.
Website
https://teknova.com
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
Teknova manufactures critical life sciences reagents—buffers, agar plates, microbial culture media, cryopreservation media, water, and proprietary AAV•Tek gene therapy solutions—for 3,000+ academic, biotech, and biopharma customers across RUO and GMP grades.
Ownership category
akta.pro rank

Teknova industry classification

Industry
Product category
Life Sciences Reagents and Manufacturing Services
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Food Manufacturing (311)
SIC
Miscellaneous Chemical Products (2890), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAGAI
Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Life science reagents
  • Custom reagent manufacturing
  • GMP manufacturing services
  • Cell therapy reagents
  • Buffer solutions

Where Teknova is headquartered

Location

Headquarters

HQ city
Hollister
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Teknova business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Off-the-shelf Catalog Products: Sale of over 1,400 ready-to-use reagent formulations including buffers, agar plates, culture media, cryopreservation media, and water products. Products available in various formats from tubes to 200L bags. Revenue from standard product catalog with various container sizes and grades (RUO, GMP).
  2. Custom Manufacturing Services: Custom reagent formulation and manufacturing services with low minimum orders (as low as 8 sleeves of agar plates or 8 L of broths/buffers). Includes custom formats, formulations, and quality control testing. Features Express•Tek Production for expedited turnaround in days instead of weeks.
  3. GMP Manufacturing: ISO 13485 certified manufacturing services for GMP-grade products supporting clinical and commercial production. Services include custom GMP reagents, OEM kitting, and stability studies for shelf-life determination.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goAAV•Tek PCR Sample Prep Kit (DNase I Treatment + Dilution Buffer)
Unit PricingPay-as-you-goCustom Manufacturing
Unit PricingMulti-year contractGMP Manufacturing Services

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Teknova product offering

Product offering

Core offering

Teknova manufactures and sells critical reagents and buffers for the life sciences industry across product lines including AAV•Tek Solutions (proprietary AAV gene therapy reagents), Agar Plates, Buffers and Reagents, PluriFreeze Cryopreservation Media, Dry Powders, Microbial Culture Media, and Water products available in RUO, RUO+, and GMP grades. The company complements its catalog with custom manufacturing, GMP manufacturing, OEM kitting, and Express•Tek expedited production services, serving over 3,000 customers in gene therapy, cell therapy, molecular diagnostics, synthetic biology, and academic research through 180,000+ square feet of ISO 13485 certified manufacturing facilities.

Product overview

Teknova is a manufacturer of critical reagents for the life sciences industry, operating as a platform of modular product lines supported by manufacturing services. The core portfolio includes AAV•Tek Solutions (proprietary AAV gene therapy reagents including PCR Sample Prep Kit, AAV Stabilizer, and AEX Buffer Screening Kit), Agar Plates, Buffers and Reagents, Cryopreservation Media (PluriFreeze), Dry Powders, Microbial Culture Media, and Water products—all available in RUO, RUO+, and GMP manufacturing grades. These product lines are complemented by service offerings including GMP Manufacturing, OEM Kitting, Express•Tek Production, and Custom Manufacturing, enabling customers to transition from research through commercialization. The company supports end-to-end workflows for AAV gene therapy and plasmid production, with over 1,400 ready-to-use formulations and more than 3,000 customers across academia, biotechnology, and biopharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

  • AAV•Tek Solutions: Proprietary suite of novel reagents designed to streamline gene therapy workflows, including AAV Stabilizer, AEX Buffer Screening Kit, and PCR Sample Prep Kit for adeno-associated virus applications.
  • PluriFreeze Cryopreservation System
  • Express•Tek Production
  • Pluristyx

Products and services

  • AAV•Tek Solutions Proprietary suite of innovative reagents designed to streamline adeno-associated virus (AAV) gene therapy workflows, addressing critical pain points in downstream processing including polishing, sample preparation, and capsid enrichment. Targeted at biopharmaceutical and biotechnology companies developing gene therapies.
  • Agar Plates Pre-poured agar plates including bacterial culture media (Brain Heart Infusion, LB, M9, MacConkey, Mannitol Salt, m-Endo, Middlebrook, MRS, Mueller Hinton, Nutrient, Plate Count, Pseudomonas, R2A, Reinforced Clostridial, Salmonella Shigella, SOB/SOC, TB, Tryptic Soy, XLD, 2xYT) and yeast and fungal culture media. Used by life sciences researchers and microbiology labs.
  • Buffers and Reagents Comprehensive range of buffers and reagents including acids and bases, additives, alcohol solutions, antibiotic solutions, biological buffers (Bis-Tris, HEPES, Histidine, MES, MOPS, PBS, Potassium Phosphate, Sodium Citrate, Tris), chaotropic agents, molecular biology solutions, salt solutions, sugar solutions, and surfactants/detergents. Used across life sciences research, molecular biology, and bioprocessing.
  • PluriFreeze Cryopreservation Media PluriFreeze cryopreservation media system including PluriFreeze Base and PluriFreeze PF10, both available in RUO and GMP grades. Novel low-viscosity solution designed for large-scale cryopreservation in closed systems. Targeted at cell therapy developers and manufacturers.
  • Dry Powders Dry powder products including additives (amino acids, plating beads), antibiotic powders, bacterial culture media (Brain Heart Infusion, LB, M9, Mueller-Hinton, SOB/SOC, Super Broth, TB, Tryptic Soy, 2xYT), salt solutions, surfactants/detergents, and yeast/fungal media. Used for microbiology and molecular biology applications.
  • Microbial Culture Media Liquid microbial culture media including bacterial culture media (Brain Heart Infusion, LB, M9 Minimal, Mueller-Hinton, Nutrient Broth, SOB/SOC, Super Broth, Synthetic Defined, TB, Tryptic Soy, 2xYT) and yeast and fungal media (Buffered Complex Broths, Complete Minimal, Sabouraud Dextrose, Synthetic Defined, Yeast Peptone Dextrose).
  • Water Products Water products including PCR Certified Water (DNase/RNase/Endotoxin Tested), Reagent Grade Water, and WFI Quality Water, available in various formats from tubes to 200L bags. Used in molecular biology, bioprocessing, and pharmaceutical applications.
  • GMP Manufacturing Services ISO 13485 certified GMP manufacturing services with over 10,000 square feet of ISO 7 and 8 cleanrooms, featuring cutting-edge automation, continuous production, and burst capacity for lot sizes up to 2,000 L. Serves clinical and commercial-stage biopharmaceutical and biotechnology customers.
  • OEM Kitting Original equipment manufacturer kitting services for assembling and packaging custom reagent configurations. Serves companies that require private-label or bundled reagent kits for their customers or distribution channels.
  • Express•Tek Production Expedited custom formulation production service that delivers products in days instead of weeks, featuring pre-ordered raw materials, prioritized manufacturing, and overnight shipping with guaranteed turnaround. Serves customers requiring fast turnaround for time-sensitive research or production needs.
  • Custom Manufacturing Custom reagent manufacturing with low minimum order quantities (as low as 8 sleeves of agar plates or 8 L of broths/buffers), flexible container formats, and comprehensive QC testing. Services include stability studies and a custom order configurator. Serves life sciences researchers and manufacturers needing tailored formulations.

Quantifiable outcome

  • Up to 50% increase in AAV yield with AAV Stabilizer
  • +4 more outcomes

Companies that use Teknova

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Teknova technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Teknova partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sartorius BIA SeparationscoreStrategic or Co-development PartnerCollaborative research partnership focused on AAV downstream processing optimization. The collaboration demonstrated successful achievement of over 85% full AAV capsid enrichment with 80-90% recoveries when pairing Teknova's optimized AEX Buffer Screening Kit with Sartorius BIA Separations' CIMmultus QA monolith. Joint webinars and published data support the partnership. Quote from Managing Director Aleš Štrancar highlights the importance of combining purification platform with buffer composition for successful AAV empty and full capsid separation.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Teknova competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: Largest life sciences tools company, with Gibco-branded cell culture media, buffers, and bioproduction reagents overlapping directly with Teknova's catalog; also serves biopharma through Patheon CDMO services and Fisher Scientific distribution that competes with Teknova's own Fisher channel.
  • Corning Life Sciences: Supplies cell culture media, sera, and bioprocess containers alongside its core lab consumables business; overlaps with Teknova's liquid microbial culture media and water products serving similar life sciences customers.
  • Bio-Techne: Public developer and manufacturer of life science reagents, proteins, and cell/gene therapy workflow tools including the recently acquired BioLegend portfolio — overlapping with Teknova's reagent and cell therapy media offerings.
  • Sartorius AG: Bioprocessing equipment and consumables leader, parent of BIA Separations — Teknova's explicit AAV downstream co-development partner. Overlapping reagent and buffer offerings make Sartorius a strategic competitor as well as collaborator.
  • Avantor: Global supplier of products, services, and solutions for life sciences and advanced technology customers, including bioproduction buffers and reagents through the VWR distribution channel that also carries Teknova's products.
  • Cytiva: Danaher-owned bioprocessing leader offering chromatography resins, buffers, and consumables including the CIMmultus QA monolith — Teknova's AAV•Tek AEX kit is paired with Cytiva/Sartorius platforms, making Cytiva a direct channel and technology peer with vastly greater scale.
  • Merck KGaA / MilliporeSigma: Operates one of the broadest portfolios of buffers, reagents, and bioprocessing inputs including the BioReliance CDMO testing services; competes across Teknova's entire catalog and offers deeper customization for larger GMP customers.
  • Lonza Group: Global biopharma CDMO and manufacturer of cell and gene therapy media and buffers; comparable to Teknova's GMP manufacturing and cryopreservation offerings but with substantially larger scale and broader service portfolio.

Direct peers

  • STEMCELL Technologies: Privately held Canadian life sciences company specializing in cell culture media, cryopreservation reagents, and cell therapy workflow products — directly comparable to Teknova's PluriFreeze and microbial culture media lines serving similar academic and biopharma customers.
  • FUJIFILM Irvine Scientific: Manufacturer of cell culture media, reagents, and GMP-grade bioprocessing inputs for cell and gene therapy — directly comparable to Teknova's GMP manufacturing services and PluriFreeze cryopreservation media targeting the same therapy developers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Teknova social profiles

Digital presence

Teknova compliance and trust

Trust signal

Compliance1 record

Teknova financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Teknova leadership team

Management profile

Number of profiles

Profiles4 records

Teknova funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Teknova M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teknova

What does Teknova do?

Teknova manufactures and sells critical reagents and buffers for the life sciences industry across product lines including AAV•Tek Solutions (proprietary AAV gene therapy reagents), Agar Plates, Buffers and Reagents, PluriFreeze Cryopreservation Media, Dry Powders, Microbial Culture Media, and Water products available in RUO, RUO+, and GMP grades. The company complements its catalog with custom manufacturing, GMP manufacturing, OEM kitting, and Express•Tek expedited production services, serving over 3,000 customers in gene therapy, cell therapy, molecular diagnostics, synthetic biology, and academic research through 180,000+ square feet of ISO 13485 certified manufacturing facilities.

Is Teknova a public or private company?

Teknova is a public company. It is classified as public and is currently operating.

When was Teknova founded?

Teknova was founded in 1996. It employs 101 to 250 people.

Where is Teknova based?

Teknova is headquartered in Hollister, United States, in the North America region.

How does Teknova make money?

Three revenue lines are on record. Off-the-shelf Catalog Products are the primary driver. The others are custom Manufacturing Services and GMP Manufacturing.

Who are Teknova's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, Corning Life Sciences, Bio-Techne, Sartorius AG, Avantor, Cytiva, Merck KGaA / MilliporeSigma and Lonza Group. Direct peers are STEMCELL Technologies and FUJIFILM Irvine Scientific.

Does Teknova have an API?

No public API is recorded for Teknova.

What industry is Teknova in?

Teknova's product category is Life Sciences Reagents and Manufacturing Services. Its primary akta.pro industry code is HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines), with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 3254 and its SIC code is 2890.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooWall Street Analysts Think Alpha Teknova (TKNO) Could Surge 26.41%: Read This Before Placing a BetWall Street analysts set a mean price target of $9.67 for Alpha Teknova, implying a 26.4% upside from its $7.65 closing price. The most optimistic estimate is $12.00, a 56.9% increase, while the lowest is $8.00. Analysts' price targets are often overly optimistic, but tight clustering may signal agreement on direction.Defense WorldAlpha Teknova (NASDAQ:TKNO) versus Charles River Laboratories International (NYSE:CRL) Critical AnalysisAlpha Teknova and Charles River Laboratories are compared on institutional ownership, analyst ratings, and valuation. Charles River has higher institutional ownership (98.9% vs 13.8%) and a better analyst consensus (2.71 vs 2.50), while Alpha Teknova shows higher potential upside (6.58% vs 7.86% downside). Charles River beats on 10 of 14 factors.YahooAlpha Teknova Inc (TKNO) (Q3 2026) Earnings Call Highlights: Record Revenue, Surging Clinical ...Alpha Teknova reported record Q3 2026 revenue of $12.2 million, up 22% year-over-year, with clinical solutions revenue surging 86% to $3.2 million. The company raised $46 million in equity capital and remains unprofitable with a net loss of $3.5 million, targeting positive adjusted EBITDA before end of 2027.Seeking AlphaTeknova lifts 2026 revenue outlook to $46M-$48M as it targets adjusted EBITDA positive at $52M-$57M annualized revenue (NASDAQ:TKNO)Teknova raised its 2026 revenue outlook to $46M-$48M and targets adjusted EBITDA positive at $52M-$57M annualized revenue. CEO Stephen Gunstream said the company delivered its second consecutive quarter of record revenue with 22% top-line growth, driven by custom product sales.Seeking AlphaAlpha Teknova, Inc. (TKNO) Q3 2026 Earnings Call TranscriptAlpha Teknova reported its Q3 2026 financial results on November 4, 2026, with CEO Stephen Gunstream and CFO Matt Lowell presenting. The company provided forward-looking statements subject to risks and uncertainties, and management emphasized non-GAAP financial measures alongside GAAP results.BenzingaAlpha Teknova Q3 2026 Earnings Call Transcript - Alpha Teknova (NASDAQ:TKNO)Alpha Teknova reported record Q3 2026 revenue up 22% year-over-year, driven by custom product sales to biopharma customers. The company raised its 2026 revenue guidance to $46-48 million and completed a $46 million equity raise. It expects positive adjusted EBITDA at annualized revenue of $52-57 million.TradingViewAlpha Teknova Q3 2026 Earnings Call Is LiveAlpha Teknova's Q3 2026 earnings call is live, with executives discussing financial results and answering analyst questions. Management commentary on demand, margins, or capital spending may move markets.MarketBeatAlpha Teknova (TKNO) Expected to Post Quarterly Earnings on WednesdayAlpha Teknova will release its Q3 2026 earnings after market close on Wednesday, November 4th. Analysts expect a loss of $0.06 per share and revenue of $11.71 million. The stock is rated Moderate Buy with an average price target of $8.75.Ticker ReportAnalyzing OmniAb (NASDAQ:OABI) and Alpha Teknova (NASDAQ:TKNO)OmniAb and Alpha Teknova are compared on revenue, earnings, analyst ratings, and institutional ownership. Alpha Teknova has higher revenue and earnings, but OmniAb has a higher consensus target price and more institutional ownership. Alpha Teknova beats OmniAb on 7 of 13 factors.Business & FinancialTeknova To Report Third Quarter 2026 Financial Results On November 4, 2026Teknova will host a webcast and conference call on November 4, 2026, to report its third-quarter 2026 financial results. The call begins at 6:00 p.m. Eastern Time, with a replay available on the company's website. The company, a life sciences reagent manufacturer, will not disclose specific financial figures in the announcement.